JP6021893B2 - 軽度認知機能障害（ＭＣＩ）およびアルツハイマー病（ＡＤ）の早期検出ならびにモニタリングのために体液からのｍｉＲＮＡを使用する方法 - Google Patents
軽度認知機能障害（ＭＣＩ）およびアルツハイマー病（ＡＤ）の早期検出ならびにモニタリングのために体液からのｍｉＲＮＡを使用する方法 Download PDFInfo
- Publication number
- JP6021893B2 JP6021893B2 JP2014506501A JP2014506501A JP6021893B2 JP 6021893 B2 JP6021893 B2 JP 6021893B2 JP 2014506501 A JP2014506501 A JP 2014506501A JP 2014506501 A JP2014506501 A JP 2014506501A JP 6021893 B2 JP6021893 B2 JP 6021893B2
- Authority
- JP
- Japan
- Prior art keywords
- mir
- mirna
- mci
- ratio
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161476591P | 2011-04-18 | 2011-04-18 | |
| US61/476,591 | 2011-04-18 | ||
| US201161478766P | 2011-04-25 | 2011-04-25 | |
| US61/478,766 | 2011-04-25 | ||
| US201161546431P | 2011-10-12 | 2011-10-12 | |
| US61/546,431 | 2011-10-12 | ||
| PCT/US2012/034025 WO2012145363A1 (en) | 2011-04-18 | 2012-04-18 | METHODS OF USING miRNA FROM BODILY FLUIDS FOR EARLY DETECTION AND MONITORING OF MILD COGNITIVE IMPAIRMENT (MCI) AND ALZHEIMER'S DISEASE (AD) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513528A JP2014513528A (ja) | 2014-06-05 |
| JP2014513528A5 JP2014513528A5 (enExample) | 2015-06-18 |
| JP6021893B2 true JP6021893B2 (ja) | 2016-11-09 |
Family
ID=47041896
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506501A Active JP6021893B2 (ja) | 2011-04-18 | 2012-04-18 | 軽度認知機能障害（ＭＣＩ）およびアルツハイマー病（ＡＤ）の早期検出ならびにモニタリングのために体液からのｍｉＲＮＡを使用する方法 |
| JP2014506516A Active JP6211511B2 (ja) | 2011-04-18 | 2012-04-18 | ｍｉＲＮＡに基づくユニバーサルスクリーニングテスト（ＵＳＴ） |
| JP2017174778A Pending JP2018027089A (ja) | 2011-04-18 | 2017-09-12 | ｍｉＲＮＡに基づくユニバーサルスクリーニングテスト（ＵＳＴ） |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014506516A Active JP6211511B2 (ja) | 2011-04-18 | 2012-04-18 | ｍｉＲＮＡに基づくユニバーサルスクリーニングテスト（ＵＳＴ） |
| JP2017174778A Pending JP2018027089A (ja) | 2011-04-18 | 2017-09-12 | ｍｉＲＮＡに基づくユニバーサルスクリーニングテスト（ＵＳＴ） |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9556487B2 (enExample) |
| EP (4) | EP2699666B1 (enExample) |
| JP (3) | JP6021893B2 (enExample) |
| CN (3) | CN105861712B (enExample) |
| AU (2) | AU2012245628B2 (enExample) |
| CA (2) | CA2833389C (enExample) |
| ES (1) | ES2630602T3 (enExample) |
| RU (1) | RU2626540C2 (enExample) |
| WO (2) | WO2012145363A1 (enExample) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2699666B1 (en) | 2011-04-18 | 2016-10-05 | DiamiR, LLC | miRNA-BASED UNIVERSAL SCREENING TEST (UST) |
| US20160289762A1 (en) | 2012-01-27 | 2016-10-06 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for profiliing and quantitating cell-free rna |
| US20140087964A1 (en) * | 2012-09-24 | 2014-03-27 | University Of Virginia Patent Foundation | Compositions and methods for detecting aberrant regulation, expression, and levels of hgh |
| US20140100124A1 (en) * | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
| EP2733219B1 (en) | 2012-11-16 | 2017-09-20 | Siemens Aktiengesellschaft | Diagnostic miRNA markers for Alzheimer |
| EP2733220B1 (en) | 2012-11-16 | 2017-10-18 | Siemens Aktiengesellschaft | Novel miRNA as a diagnostic marker for Alzheimer's Disease |
| CN104903468B (zh) | 2012-11-16 | 2019-04-23 | 萨尔大学 | 用于帕金森氏病的新诊断MiRNA标志物 |
| JP2014128249A (ja) * | 2012-12-28 | 2014-07-10 | Hokkaido Univ | 神経変性疾患の検査と治療に対するｍｉＲＮＡ又はその標的遺伝子の利用 |
| CN103805693B (zh) * | 2013-10-29 | 2017-01-11 | 宁夏医科大学 | 微小分子RNA-508-5p作为抗肿瘤标志物的用途 |
| JP6930832B2 (ja) * | 2013-11-18 | 2021-09-01 | ディアミール, エルエルシーDiamir, Llc | パーキンソン病（ＰＤ）の検出およびモニタリングのための、体液からのｍｉＲＮＡを使用する方法 |
| CA2939343A1 (en) * | 2014-02-18 | 2015-08-27 | Baylor Research Institute | Mir-320e and colorectal cancer |
| KR102505827B1 (ko) * | 2014-04-10 | 2023-03-03 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 이식거부 및 면억억제 요법의 내성을 진단하기 위한 마이크로 리보핵산(miRNA)의 용도 |
| CN103937888B (zh) * | 2014-04-14 | 2016-08-17 | 上海交通大学 | 鉴别胃癌的血浆microRNA标志物的筛选与应用 |
| WO2015164431A2 (en) * | 2014-04-22 | 2015-10-29 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers |
| WO2015181825A1 (en) * | 2014-05-28 | 2015-12-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods of glucocorticoid therapy and determining responsiveness thereof |
| CA3224457A1 (en) * | 2014-06-18 | 2015-12-23 | Toray Industries, Inc. | Esophageal cancer detection kit or device, and detection method |
| US10487324B2 (en) | 2015-02-25 | 2019-11-26 | Washington University | Methods to detect motor neuron disease comprising micro-RNAs |
| HK1249182A1 (zh) * | 2015-05-28 | 2018-10-26 | Immunexpress Pty Ltd | 验证生物标志物测量 |
| WO2016197024A2 (en) | 2015-06-05 | 2016-12-08 | MiRagen Therapeutics, Inc. | Mir-155 inhibitors for treating cutaneous t cell lymphoma (ctcl) |
| CN104940954B (zh) * | 2015-06-23 | 2017-12-26 | 同济大学 | MicroRNA‑7在制备抗胶质化药物中的应用 |
| US20180355346A1 (en) * | 2015-09-11 | 2018-12-13 | Corning Incorporated | Compositions and methods for nucleic acid purification from blood samples |
| ES2734678T3 (es) * | 2015-12-22 | 2019-12-11 | Siemens Ag | Firmas específicas en enfermedad de alzheimer por perfiles de miarn multicéntricos |
| WO2017120285A1 (en) * | 2016-01-05 | 2017-07-13 | Diamir, Llc | METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS |
| US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
| US11149313B2 (en) | 2016-03-21 | 2021-10-19 | Diamir, Llc | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases |
| WO2017186719A1 (en) * | 2016-04-25 | 2017-11-02 | Instytut Biologii Doswiadczalnej Im. Marcelego Nenckiego Polska Akademia Nauk | Microrna biomarkers in blood for diagnosis of alzheimer's disease |
| CN109716129B (zh) | 2016-09-16 | 2023-10-03 | 武田药品工业株式会社 | 用于遗传性血管性水肿的rna生物标记 |
| GB201616691D0 (en) | 2016-09-30 | 2016-11-16 | King S College London | Assay |
| CN106544435A (zh) * | 2016-09-30 | 2017-03-29 | 河北医科大学第医院 | 检测miR‑206所需逆转录引物对在制备预测试剂盒中的应用 |
| SG10201709799SA (en) * | 2016-11-29 | 2018-06-28 | Helios Bioelectronics Inc | Method for quantitatively profiling nucleic acids |
| JP7107477B2 (ja) * | 2016-12-28 | 2022-07-27 | 国立大学法人 熊本大学 | ミトコンドリアｔＲＮＡ修飾の検出法 |
| WO2018139759A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 알츠하이머병 진단방법 |
| AU2018300159A1 (en) * | 2017-07-12 | 2020-02-06 | Texas Tech University System | MicroRNA-455-3p as a peripheral biomarker for Alzheimer's disease |
| US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
| KR101830583B1 (ko) * | 2017-08-11 | 2018-02-20 | 주식회사 인피니트헬스케어 | Ｗｓｉ 스트리밍 방법 |
| WO2019060298A1 (en) | 2017-09-19 | 2019-03-28 | Neuroenhancement Lab, LLC | METHOD AND APPARATUS FOR NEURO-ACTIVATION |
| CN107811609B (zh) * | 2017-09-22 | 2020-06-09 | 中国医学科学院北京协和医院 | 一种脑老化评估系统 |
| CA3083140A1 (en) * | 2017-11-30 | 2019-06-06 | Provincial Health Services Authority | Methods for evaluating head and neck cancers |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| EP4697021A3 (en) | 2018-02-13 | 2026-05-20 | Toray Industries | DEMENTIA DETECTION KIT OR DEVICE AND METHOD |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| RU2677280C1 (ru) * | 2018-05-17 | 2019-01-16 | федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ диагностики многососудистого атеросклеротического поражения коронарных артерий у больных ишемической болезнью сердца при абдоминальном ожирении |
| US11332789B2 (en) | 2018-05-21 | 2022-05-17 | Temple University-Of The Commonwealth System Of Higher Education | Compositions and methods for diagnosing and treating hyperlipidemia-related diseases |
| EP3807422B1 (en) | 2018-06-15 | 2025-12-03 | Universitat Autònoma de Barcelona | Circulating mirnas as biomarkers for diagnosis of mild cognitive impairment and alzheimer´s disease |
| CN113382683A (zh) | 2018-09-14 | 2021-09-10 | 纽罗因恒思蒙特实验有限责任公司 | 改善睡眠的系统和方法 |
| CN109055541B (zh) * | 2018-09-26 | 2020-08-28 | 上海市精神卫生中心（上海市心理咨询培训中心） | Ad所致mci诊断标志物及其应用 |
| US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
| US11198908B2 (en) | 2019-06-17 | 2021-12-14 | Biorchestra Co., Ltd. | Method for diagnosis of Alzheimer's disease using microRNA |
| KR20220024160A (ko) * | 2019-06-17 | 2022-03-03 | 주식회사 바이오오케스트라 | 마이크로rna를 이용하여 알츠하이머 질환 동물 모델을 준비하기 위한 조성물 및 방법 |
| WO2021024331A1 (ja) | 2019-08-02 | 2021-02-11 | 株式会社 東芝 | 分析方法及びキット |
| KR20230014705A (ko) * | 2020-04-23 | 2023-01-30 | 주식회사 바이오오케스트라 | Mir-485-3p 발현을 사용하는 진단 방법 |
| US20220073992A1 (en) * | 2020-11-24 | 2022-03-10 | Hossein Abdul Tehrani Abdul Tehrani | Diagnosis of chronic kidney disease (ckd) and its subgroups |
| CN112562867A (zh) * | 2021-02-22 | 2021-03-26 | 天津迈德新医药科技有限公司 | 一种预测极早期hiv感染风险的装置、存储介质和电子装置 |
| CN112980954B (zh) * | 2021-03-03 | 2022-02-25 | 首都医科大学宣武医院 | 一种预测神经退行性疾病风险的试剂盒及其用途 |
| CN115976194A (zh) * | 2022-12-12 | 2023-04-18 | 天津市肿瘤医院空港医院 | 一种基于外泌体微小rna的神经系统疾病诊断方法 |
| WO2025089057A1 (ja) * | 2023-10-24 | 2025-05-01 | アークレイ株式会社 | スモールｒｎａ測定用血液試料の調製方法及び保存方法、スモールｒｎａの発現量の測定方法、疾患の判定方法、検査方法、モデルの生成方法、検査装置、検査システム、検査プログラム、並びに記録媒体 |
| WO2026094719A1 (ja) * | 2024-10-28 | 2026-05-07 | アークレイ株式会社 | 標準物質及び品質保証方法 |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US743A (en) | 1838-05-17 | Improvement in plows | ||
| US5071A (en) | 1847-04-17 | George page | ||
| FR2552909B1 (fr) | 1983-09-30 | 1985-11-08 | Thomson Csf | Appareil indicateur cartographique de relief et son u tilisation pour la navigation aerienne |
| US4829304A (en) | 1986-05-20 | 1989-05-09 | Harris Corp. | Map-aided navigation system employing TERCOM-SITAN signal processing |
| KR940002799B1 (ko) | 1986-07-28 | 1994-04-02 | 가부시끼가이샤 도요다지도오쇽기 세이사꾸쇼 | 보텀 드래프트 로울러의 청소장치 |
| US4939663A (en) | 1988-04-04 | 1990-07-03 | Harris Corporation | Elevation map-referenced mechanism for updating vehicle navigation system estimates |
| EP0381178A1 (en) | 1989-02-02 | 1990-08-08 | Honeywell Inc. | Method and apparatus for aircraft navigation |
| US5071743A (en) | 1989-10-27 | 1991-12-10 | Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada | Process for conducting site-directed mutagenesis |
| JP3442774B2 (ja) | 1991-07-01 | 2003-09-02 | バーレックス ラボラトリーズ，インコーポレイティド | 新規な突然変異誘発法および組成物 |
| US5789166A (en) | 1995-12-08 | 1998-08-04 | Stratagene | Circular site-directed mutagenesis |
| US6242222B1 (en) | 1996-06-07 | 2001-06-05 | Massachusetts Institute Of Technology | Programmed sequential mutagenesis |
| US5780270A (en) | 1996-07-17 | 1998-07-14 | Promega Corporation | Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity |
| EP2290073A3 (en) | 2004-05-28 | 2011-08-31 | Asuragen, Inc. | Methods and compositions involving microRNA |
| CA2857878A1 (en) | 2004-11-12 | 2006-12-28 | Asuragen, Inc. | Methods and compositions involving mirna and mirna inhibitor molecules |
| EP1966390A1 (en) | 2005-12-29 | 2008-09-10 | Exiqon A/S | Detection of tissue origin of cancer |
| EP2484782B1 (en) * | 2006-01-05 | 2015-11-18 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| US7799531B2 (en) | 2006-02-28 | 2010-09-21 | University Of Louisville Research Foundation | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms |
| WO2008036765A2 (en) * | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| WO2008045505A2 (en) | 2006-10-10 | 2008-04-17 | Xenomics, Inc. | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| AU2007347449A1 (en) * | 2007-02-16 | 2008-08-28 | The Johns Hopkins University | The microRNAome |
| WO2008153692A2 (en) | 2007-05-22 | 2008-12-18 | The Brigham And Women's Hospital, Inc. | Microrna expression profiling of cerebrospinal fluid |
| US20090004668A1 (en) | 2007-06-22 | 2009-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Pre-miRNA loop-modulated target regulation |
| WO2009009457A1 (en) | 2007-07-06 | 2009-01-15 | University Of Louisville Research Foundation, Inc. | Alzheimer's disease-specific micro-rna microarray and related methods |
| KR20100049079A (ko) | 2007-07-18 | 2010-05-11 | 더 리젠트스 오브 더 유니버시티 오브 콜로라도 | 인간의 정상 심장과 기능부진 심장에서 마이크로 ｒｎａ의 차등 발현 |
| EP2613149B1 (en) | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
| ES2660785T3 (es) | 2007-08-22 | 2018-03-26 | Trovagene, Inc. | Métodos de uso de ARNmi para la detección de la muerte de células in vivo |
| US7653509B2 (en) | 2007-08-29 | 2010-01-26 | Verity Software House | Probability state models |
| US7993831B2 (en) | 2007-09-14 | 2011-08-09 | Asuragen, Inc. | Methods of normalization in microRNA detection assays |
| EP2610342B1 (en) * | 2007-09-14 | 2016-05-04 | The Ohio State University Research Foundation | MiRNA Expression in Human Peripheral Blood Microvesicles and uses Thereof |
| CN101918594A (zh) | 2007-11-30 | 2010-12-15 | 俄亥俄州立大学研究基金会 | 肺癌中外周血中的微rna表达特征谱和靶向 |
| ES2936256T3 (es) | 2008-02-01 | 2023-03-15 | Massachusetts Gen Hospital | Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas |
| CA2716906A1 (en) * | 2008-02-28 | 2009-09-03 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer |
| RU2367959C1 (ru) * | 2008-03-05 | 2009-09-20 | Государственное образовательное учреждение высшего профессионального образования "Омский государственный университет им. Ф.М. Достоевского" | Способ лабораторной диагностики заболеваний ротовой полости по элементному составу слюны |
| WO2009114681A2 (en) | 2008-03-13 | 2009-09-17 | Dharmacon, Inc. | Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy |
| WO2009120877A2 (en) | 2008-03-26 | 2009-10-01 | The Johns Hopkins University | Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| EP2271931A4 (en) | 2008-04-25 | 2011-10-12 | Merck Sharp & Dohme | MICRO-RNA BIOMARKERS FOR TISSUE INJURIES |
| EP2281903B1 (en) | 2008-04-30 | 2017-01-04 | NEC Corporation | METHOD FOR EVALUATION OF CANCER BY USING miRNA CANCER MARKER |
| WO2009143379A2 (en) * | 2008-05-21 | 2009-11-26 | Fred Hutchinson Cancer Research Center | Use of extracellular rna to measure disease |
| US20100167937A1 (en) | 2008-07-08 | 2010-07-01 | Power3 Medical Products, Inc. | Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum |
| EP3211098B1 (en) | 2008-11-10 | 2023-03-15 | Battelle Memorial Institute | Method utilizing microrna to determine physiological conditions |
| CA2743211A1 (en) | 2008-11-12 | 2010-05-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems of using exosomes for determining phenotypes |
| US20110086348A1 (en) * | 2009-02-19 | 2011-04-14 | The Cleveland Clinic Foundation | Method for assessing heart disease |
| CA2679784A1 (en) | 2009-03-05 | 2010-09-05 | Newcastle Innovation Limited | Diagnostic, prognostic and treatment methods |
| EP2414549A4 (en) * | 2009-03-31 | 2013-08-28 | Us Health | DIFFERENTIALLY EXPRESSED MICRO-RNAS AS BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN SYNDROME |
| WO2010118979A1 (en) | 2009-04-07 | 2010-10-21 | Velin-Pharma A/S | Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system |
| CA2757711A1 (en) * | 2009-04-14 | 2010-10-21 | Merck Sharp & Dohme Corp. | Microrna as a biomarker of pancreatic islet beta-cell engagement |
| EP2433304A1 (en) | 2009-05-20 | 2012-03-28 | E. I. du Pont de Nemours and Company | Process of forming a grid electrode on the front-side of a silicon wafer |
| FR2948687B1 (fr) * | 2009-07-29 | 2015-09-04 | Centre Nat Rech Scient | Utilisation de microarn pour le traitement de pathologies respiratoires chroniques |
| CN102725632A (zh) * | 2009-08-28 | 2012-10-10 | 奥斯瑞根公司 | 肺病的miRNA生物标志物 |
| ES2597554T3 (es) | 2009-11-04 | 2017-01-19 | Diamir, Llc | Métodos de utilización de micro-ARN de fluidos corporales para el diagnóstico y control del deterioro cognitivo leve |
| US8592151B2 (en) * | 2009-11-17 | 2013-11-26 | Musc Foundation For Research Development | Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids |
| CN101942502B (zh) | 2009-12-24 | 2014-09-17 | 北京命码生科科技有限公司 | 胰腺癌标记物及其检测方法、试剂盒和生物芯片 |
| EP3124623B1 (en) | 2010-04-20 | 2018-03-28 | Hummingbird Diagnostics GmbH | Complex mirna sets as novel biomarkers for an acute coronary syndrome |
| HUE051674T2 (hu) | 2010-09-24 | 2021-03-29 | Niels Grabe | Eszközök és eljárások rákos beteg kezelésére adott válaszának elõrejelzésére |
| CN101962685B (zh) | 2010-11-11 | 2012-09-19 | 江苏省疾病预防控制中心 | 一种基于液相芯片检测微小核糖核酸的方法 |
| EP2699666B1 (en) | 2011-04-18 | 2016-10-05 | DiamiR, LLC | miRNA-BASED UNIVERSAL SCREENING TEST (UST) |
| EP2744910B1 (en) | 2011-08-19 | 2016-09-14 | Hummingbird Diagnostics GmbH | Complex sets of mirnas as non-invasive biomarkers for kidney cancer |
| WO2013036936A1 (en) | 2011-09-09 | 2013-03-14 | Van Andel Research Institute | Microrna biomarkers for diagnosing parkinson's disease |
| US9447471B2 (en) | 2011-12-29 | 2016-09-20 | Quest Diagnostics Investments Incorporated | Microrna profiling for diagnosis of dysplastic nevi and melanoma |
| US9540692B2 (en) | 2012-07-25 | 2017-01-10 | Rush University Medical Center | MiRNAs as novel therapeutic targets and diagnostic biomarkers for parkinsons disease |
| US9809857B2 (en) | 2013-02-28 | 2017-11-07 | Washington University | Methods and signatures for oropharyngeal cancer prognosis |
| JP6930832B2 (ja) | 2013-11-18 | 2021-09-01 | ディアミール, エルエルシーDiamir, Llc | パーキンソン病（ＰＤ）の検出およびモニタリングのための、体液からのｍｉＲＮＡを使用する方法 |
| US9605315B2 (en) | 2014-03-26 | 2017-03-28 | The University Of Montana | Detection of traumatic brain injury |
| US9708667B2 (en) | 2014-05-13 | 2017-07-18 | Rosetta Genomics, Ltd. | MiRNA expression signature in the classification of thyroid tumors |
| WO2017120285A1 (en) | 2016-01-05 | 2017-07-13 | Diamir, Llc | METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS |
| US11149313B2 (en) | 2016-03-21 | 2021-10-19 | Diamir, Llc | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases |
| EP3464639A4 (en) | 2016-05-31 | 2020-01-01 | Goetzl, Edward, J. | DIAGNOSTIC METHOD AND DRUG EFFECT TEST METHOD FOR DEMENTIA WITH THE USE OF ASTROCYTE-DERIVED EXOSOMES |
-
2012
- 2012-04-18 EP EP12774179.1A patent/EP2699666B1/en active Active
- 2012-04-18 CA CA2833389A patent/CA2833389C/en active Active
- 2012-04-18 ES ES12774179.1T patent/ES2630602T3/es active Active
- 2012-04-18 WO PCT/US2012/034025 patent/WO2012145363A1/en not_active Ceased
- 2012-04-18 EP EP16192259.6A patent/EP3133147B1/en active Active
- 2012-04-18 WO PCT/US2012/034098 patent/WO2012145409A1/en not_active Ceased
- 2012-04-18 US US14/112,765 patent/US9556487B2/en active Active
- 2012-04-18 RU RU2013146856A patent/RU2626540C2/ru active
- 2012-04-18 CN CN201610344816.5A patent/CN105861712B/zh active Active
- 2012-04-18 AU AU2012245628A patent/AU2012245628B2/en active Active
- 2012-04-18 JP JP2014506501A patent/JP6021893B2/ja active Active
- 2012-04-18 CN CN201280030033.XA patent/CN103620019B/zh active Active
- 2012-04-18 EP EP12773705.4A patent/EP2699697B1/en active Active
- 2012-04-18 AU AU2012245580A patent/AU2012245580B2/en active Active
- 2012-04-18 CN CN201280030048.6A patent/CN103620057B/zh active Active
- 2012-04-18 JP JP2014506516A patent/JP6211511B2/ja active Active
- 2012-04-18 EP EP17207859.4A patent/EP3327145A1/en not_active Withdrawn
- 2012-04-18 CA CA2833375A patent/CA2833375A1/en active Pending
- 2012-04-18 US US14/112,684 patent/US9803242B2/en active Active
-
2016
- 2016-12-23 US US15/390,110 patent/US10246747B2/en active Active
-
2017
- 2017-05-26 US US15/606,747 patent/US10472681B2/en active Active
- 2017-09-12 JP JP2017174778A patent/JP2018027089A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103620057B (zh) | 使用来自体液的miRNA来早期检测和监控轻度认知障碍(MCI)和阿尔茨海默病(AD)的方法 | |
| US8648017B2 (en) | Methods of using small RNA from bodily fluids for diagnosis and monitoring of neurodegenerative diseases | |
| CA2931082C (en) | Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd) | |
| US11149313B2 (en) | Methods of using miRNAs from bodily fluids for detection and differentiation of neurodegenerative diseases | |
| EP3828287B1 (en) | Mci diagnosis marker due to ad and application thereof | |
| US20220259658A1 (en) | miRNA MARKER FOR DIAGNOSIS AND/OR TREATMENT OF ALZHEIMER'S DISEASE | |
| WO2017120285A1 (en) | METHODS OF USING miRNA FROM BODILY FLUIDS FOR DIAGNOSIS AND MONITORING OF NEURODEVELOPMENTAL DISORDERS | |
| EP3083987B1 (en) | Determination of platelet-mirnas in alzheimer's disease | |
| US10975436B2 (en) | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150420 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150420 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160316 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160616 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160908 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20161004 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6021893 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |